410
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Tyler asbestos workers: A mortality update in a cohort exposed to amosite

, , , &

References

  • Acheson, E. D., C. Bennett, M. J. Gardiner, and P. D. Winter. 1981. Mesothelioma in a factory using amosite and chrysotile asbestos. Lancet 2:1403–6. doi:10.1016/S0140-6736(81)92813-0.
  • Acheson, E. D., M. J. Gardiner, P. D. Winter, and C. Bennett. 1984. Cancer in a factory using amosite asbestos. International Journal of Epidemiology 13:3–10. doi:10.1093/ije/13.1.3.
  • Carlin, D. J., T. C. Larson, J. C. Pfau, S. H. Gavett, A. Shukla, A. Miller, and R. Hines. 2015. Current research and opportunities to address environmental asbestos exposures. Environment Health Perspective 123:A194–A197.
  • Churg, A., and S. Vedal. 1994. Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. American Journal of Respiratory Cell and Molecular Biology 150:663–69.
  • Delgermaa, V., K. Takahashi, E.-K. Park, G. V. Le, T. Hara, and T. Sorahan. 2011. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bulletin of the World Health Organization 89:716–24. doi:10.2471/BLT.00.000000.
  • Dodson, R. F. 2011. Analysis and relevance of asbestos burden in tissue. In Asbestos: Risk assessment, epidemiology, and health effects, 2nd ed., ed. R. F. Dodson and S. P. Hammar, 49–108. New York, NY: CRC Press, Taylor & Francis Group.
  • Dodson, R. F., and S. P. Hammar, eds. 2011. Asbestos: Risk assessment, epidemiology, and health effects, 2nd ed. New York, NY: CRC Press, Taylor & Francis Group.
  • Dodson, R. F., J. L. Levin, and P. P. Rountree. 2015. Health effects. In Managing asbestos in buildings: A guide for owners and managers, 20–26. Chevy Chase, MD: Environmental Information Association, Inc.
  • Dodson, R. F., M. F. O’Sullivan, J. Huang, D. B. Holiday, and S. P. Hammar. 2000. Asbestos in extrapulmonary sites: Omentum and mesentery. Chest 117:486–93. doi:10.1378/chest.117.2.486.
  • Finnish Institute of Occupational Health. 2014. Asbestos, asbestosis, and cancer: Helsinki criteria for diagnosis and attribution, ed. P. Oksa, H. Wolff, T. Vehmas, P. Pallasaho, and H. Frilander. Tampere, Finland: Juvenes Print.
  • Hurst, G. A., C. G. Spivey, W. T. Matlage, J. M. Miller, G. Faulk, L. R. Hieger, J. W. McLarty, and S. D. Greenberg. 1979. The Tyler Asbestos Workers Program. I. A medical surveillance model and method. Archives of Environmental Health 34:432–39. doi:10.1080/00039896.1979.10667445.
  • International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. 2012. Asbestos: Chrysotile, amosite, crocidolite, tremolite, actinolite, and anthophyllite, in a review of human carcinogens, Part C: Arsenic, metals, fibres, and dusts. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 100C, 219–310. Lyon, France: IARC.
  • Jarvholm, B., and E. Astrom. 2014. The risk of lung cancer after cessation of asbestos exposure in construction workers using pleural malignant mesothelioma as a marker of exposure. Journal of Occupational and Environmental Medicine 56:1297–301. doi:10.1097/JOM.0000000000000258.
  • Johnson, W. M., R. A. Lemen, G. A. Hurst, R. M. Spiegel, and F. H. Y. Liu. 1982. Respiratory morbidity among workers in an amosite asbestos insulation plant. Journal of Occupational Medicine 24:994–99.
  • Levin, J. L., J. W. McLarty, G. A. Hurst, A. N. Smith, and A. L. Frank. 1998. Tyler asbestos workers: Mortality experience in a cohort exposed to amosite. Occupational and Environmental Medicine 55:155–60. doi:10.1136/oem.55.3.155.
  • Levin, J. L., and P. P. Rountree. 2011. Core curriculum for practicing physicians related to asbestos. In Asbestos: Risk assessment, epidemiology, and health effects, 2nd ed., ed. R. F. Dodson and S. P. Hammar, 593–616. New York, NY: CRC Press, Taylor & Francis Group.
  • Pairon, J.-C., F. Laurent, M. Rinaldo, B. Clin, P. Andujar, J. Ameille, P. Brochard, S. Chammings, G. Ferretti, F. Galateau-Salle, A. Gislard, M. Letourneux, A. Luc, E. Schorle, and C. Paris. 2013. Pleural plaques and the risk of pleural mesothelioma. Journal of the National Cancer Institute 105:293–301. doi:10.1093/jnci/djs513.
  • Ribak, J., and G. Ribak. 2008. Human health effects associated with the commercial use of grunerite asbestos (amosite): Paterson, NJ; Tyler, TX; Uxbridge, UK. Regulatory Toxicology and Pharmacology 52 (1):S82–90. doi:10.1016/j.yrtph.2007.10.002.
  • Ribak, J., H. Seidman, and I. J. Selikoff. 1989. Amosite mesothelioma in a cohort of asbestos workers. Scandinavian Journal of Work Environment & Health 15:106–10. doi:10.5271/sjweh.1877.
  • Samet, J. M., L. R. Bristow, H. Checkoway, P. Demers, E. A. Eisen, G. D. Guthrie, R. F. Henderson, J. W. Hogan, A. B. Kane, F. R. Khuri, R. B. Ness, and M. J. Thun. 2006. Asbestos-selected cancers. Committee on Asbestos: Selected health effects, board on population health and public health practices. Institute of Medicine of the National Academies. Washington, DC: National Academies Press.
  • Seidman, H., I. J. Selikoff, and S. K. Gelb. 1986. Mortality experience of amosite asbestos factory workers: Dose-response relationships 5 to 40 years after onset of short term work exposure. American Journal of Industrial Medicine 10:479–514. doi:10.1002/ajim.v10.5/6.
  • Seidman, H., I. J. Selikoff, and E. C. Hammond. 1979. Short-term asbestos work exposure and long-term observation. Annals of the New York Academy of Sciences 330:61–89. doi:10.1111/nyas.1979.330.issue-1.
  • Selikoff, I. J., E. C. Hammond, and J. Churg. 1972. Carcinogenicity of amosite asbestos. Archives of Environmental Health 25:183–86. doi:10.1080/00039896.1972.10666158.
  • Syracuse Research Corporation. 2001. Toxicological profile for asbestos (update). Contract no. 205-1999-00024. Prepared for the U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, September. http://www.atsdr.cdc.gov/toxprofiles/TP.asp?id=30&tid=4
  • World Health Organization. 2014. Asbestos: Elimination of asbestos-related diseases. Fact sheet no. 343. http://www.who.int/mediacentre/factsheets/fs343/en ( accessed January 3, 2016).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.